Seeking Alpha13/11/2026 09:40:14

CapsoVision outlines $1B initial colon opportunity as it targets FDA submission before year-end 2026

CapsoVision outlines $1B initial colon opportunity as it targets FDA submission before year-end 2026

21 min ago
View Original Source
Seeking Alpha

Seeking Alpha

Seeking Alpha is the leading platform for investors to research and discuss US-traded stocks and ETFs. Our platform helps investors to find successful investing ideas and to successfully manage their portfolios. It provides investment ideas, analysis, news, ratings, investing tools and community discussion.

More from Seeking Alpha

Journey Medical anticipates Emrosi addition to a national plan with over 25M lives beginning 2027

11 min ago

Lulu’s outlines $5M annualized savings amid revised 2026 outlook and financing talks

11 min ago

Relmada outlines NDV-01 IND submission by year-end 2026 with cash runway through 2029

11 min ago

Codexis reiterates $72M-$76M 2026 revenue outlook while extending cash runway through 2028

11 min ago